Remko Schotte

2.7k total citations · 1 hit paper
23 papers, 1.8k citations indexed

About

Remko Schotte is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Remko Schotte has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 9 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Remko Schotte's work include Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (11 papers). Remko Schotte is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (11 papers). Remko Schotte collaborates with scholars based in Netherlands, United Kingdom and France. Remko Schotte's co-authors include Hergen Spits, Maho Nagasawa, Bianca Blom, Ton N. Schumacher, Sjoerd H. van der Burg, Els M.E. Verdegaal, Marit M. van Buuren, John B.A.G. Haanen, Marten Visser and Kees Weijer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Remko Schotte

22 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

2014 527 citations Carsten Linnemann, Marit M. van Buuren et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Remko Schotte Netherlands	14	1.4k	923	468	133	99	23	1.8k
Valarie McCullar United States	23	2.2k 1.6×	1.2k 1.2×	477 1.0×	96 0.7×	142 1.4×	32	2.8k
Sander Kelderman Netherlands	10	1.2k 0.9×	1.4k 1.5×	526 1.1×	169 1.3×	113 1.1×	12	2.0k
Willemijn Hobo Netherlands	26	1.5k 1.1×	1.3k 1.4×	520 1.1×	79 0.6×	138 1.4×	50	2.2k
Ranjani Rajapaksa United States	17	1.3k 0.9×	807 0.9×	605 1.3×	122 0.9×	221 2.2×	23	1.9k
Nienke van Rooij Netherlands	12	1.3k 0.9×	1.2k 1.3×	611 1.3×	115 0.9×	122 1.2×	22	1.9k
Raquel Gomez-Eerland Netherlands	10	907 0.6×	913 1.0×	426 0.9×	142 1.1×	80 0.8×	14	1.4k
Inmaculada Rodríguez Spain	19	991 0.7×	1.0k 1.1×	285 0.6×	118 0.9×	121 1.2×	24	1.5k
Idit Sagiv-Barfi United States	14	1.3k 0.9×	1.1k 1.2×	371 0.8×	93 0.7×	156 1.6×	32	1.9k
Jake Y. Henry United Kingdom	12	1.1k 0.8×	1.1k 1.2×	411 0.9×	72 0.5×	145 1.5×	18	1.7k
Victor Peperzak Netherlands	21	1.4k 1.0×	486 0.5×	699 1.5×	89 0.7×	79 0.8×	42	2.1k

Countries citing papers authored by Remko Schotte

Since Specialization

Citations

This map shows the geographic impact of Remko Schotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remko Schotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remko Schotte more than expected).

Fields of papers citing papers by Remko Schotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remko Schotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remko Schotte. The network helps show where Remko Schotte may publish in the future.

Co-authorship network of co-authors of Remko Schotte

This figure shows the co-authorship network connecting the top 25 collaborators of Remko Schotte. A scholar is included among the top collaborators of Remko Schotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remko Schotte. Remko Schotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kedde, Martijn, Vanessa Clerico Mosina, Bradley R. Pieters, et al.. (2025). 17P KBA1413: An antibody derived from a cured AML patient, recognizes a unique glycoepitope shared by AML, MDS and several solid cancer cells. ESMO Open. 10. 104173–104173. 1 indexed citations

Schotte, Remko, Julien Villaudy, Martijn Kedde, et al.. (2020). 580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection. Annals of Oncology. 31. S492–S492. 1 indexed citations

Kedde, Martijn, Els M.E. Verdegaal, Etsuko Yasuda, et al.. (2020). Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo. Cancer Immunology Immunotherapy. 70(6). 1569–1581. 9 indexed citations

Villaudy, Julien, Remko Schotte, Wouter Pos, et al.. (2020). 582P Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of precursor B ALL. Annals of Oncology. 31. S493–S493. 3 indexed citations

Schotte, Remko, Julien Villaudy, Els M.E. Verdegaal, et al.. (2018). 14 A patient derived antibody targeting the tetraspanin CD9 inhibits tumour progression and metastasis. ESMO Open. 3. A6–A7. 1 indexed citations

Verdegaal, Els M.E., Noel F.C.C. de Miranda, Marten Visser, et al.. (2016). Neoantigen landscape dynamics during human melanoma–T cell interactions. Nature. 536(7614). 91–95. 339 indexed citations

Linnemann, Carsten, Marit M. van Buuren, Laura Bies, et al.. (2016). High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma (vol 21, pg 81, 2015). Pure Amsterdam UMC. 22(10).

Villaudy, Julien, Remko Schotte, Nicolas Legrand, & Hergen Spits. (2014). Critical assessment of human antibody generation in humanized mouse models. Journal of Immunological Methods. 410. 18–27. 25 indexed citations

Linnemann, Carsten, Marit M. van Buuren, Laura Bies, et al.. (2014). High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nature Medicine. 21(1). 81–85. 527 indexed citations breakdown →

10.

Jorritsma, Annelies, Remko Schotte, Miriam Coccoris, Moniek A. de Witte, & Ton N. Schumacher. (2011). Prospects and Limitations of T Cell Receptor Gene Therapy. Current Gene Therapy. 11(4). 276–287. 29 indexed citations

11.

Schotte, Remko, Wendy Dontje, Maho Nagasawa, et al.. (2010). Synergy between IL-15 and Id2 Promotes the Expansion of Human NK Progenitor Cells, Which Can Be Counteracted by the E Protein HEB Required To Drive T Cell Development. The Journal of Immunology. 184(12). 6670–6679. 35 indexed citations

12.

Schotte, Remko, Heike Schmidlin, Maho Nagasawa, et al.. (2009). Isolation and In Vitro Generation of Gene-Manipulated Human Plasmacytoid and Conventional Dendritic Cells. Methods in molecular biology. 595. 67–85. 6 indexed citations

13.

Nagasawa, Maho, Heike Schmidlin, Mark G. Hazekamp, Remko Schotte, & Bianca Blom. (2008). Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix‐loop‐helix factor E2‐2 and the Ets factor Spi‐B. European Journal of Immunology. 38(9). 2389–2400. 118 indexed citations

14.

Schmidlin, Heike, Sean A. Diehl, Maho Nagasawa, et al.. (2008). Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood. 112(5). 1804–1812. 58 indexed citations

15.

Lent, Anja U. van, Maho Nagasawa, Marleen M. van Loenen, et al.. (2007). Functional Human Antigen-Specific T Cells Produced In Vitro Using Retroviral T Cell Receptor Transfer into Hematopoietic Progenitors. The Journal of Immunology. 179(8). 4959–4968. 38 indexed citations

16.

Scheeren, Ferenc A., Marianne Naspetti, Sean A. Diehl, et al.. (2005). STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nature Immunology. 6(3). 303–313. 127 indexed citations

17.

Dontje, Wendy, Remko Schotte, Tom Cupedo, et al.. (2005). Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B. Blood. 107(6). 2446–2452. 80 indexed citations

18.

Schotte, Remko, Maho Nagasawa, Kees Weijer, Hergen Spits, & Bianca Blom. (2004). The ETS Transcription Factor Spi-B Is Required for Human Plasmacytoid Dendritic Cell Development. The Journal of Experimental Medicine. 200(11). 1503–1509. 139 indexed citations

19.

Schotte, Remko, Marie‐Clotilde Rissoan, Nathalie Bendriss‐Vermare, et al.. (2003). The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development. Blood. 101(3). 1015–1023. 94 indexed citations

20.

Blom, Bianca, et al.. (2002). Developmental origin of pre-DC2. Human Immunology. 63(12). 1072–1080. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact